0
false
false
false
false
false
false
false
false
false
true
false
false
false
false
false
false
No description of principal activity
2022-01-01
Sage Accounts Production Advanced 2021 - FRS102_2021
1,179
1,179
98
98
1,081
xbrli:pure
xbrli:shares
iso4217:GBP
11092815
2022-01-01
2022-12-31
11092815
2022-12-31
11092815
2021-12-31
11092815
bus:RegisteredOffice
2022-01-01
2022-12-31
11092815
bus:LeadAgentIfApplicable
2022-01-01
2022-12-31
11092815
bus:Director1
2022-01-01
2022-12-31
11092815
bus:Director2
2022-01-01
2022-12-31
11092815
core:WithinOneYear
2022-12-31
11092815
core:WithinOneYear
2021-12-31
11092815
core:ShareCapital
2022-12-31
11092815
core:ShareCapital
2021-12-31
11092815
core:RetainedEarningsAccumulatedLosses
2022-12-31
11092815
core:RetainedEarningsAccumulatedLosses
2021-12-31
11092815
core:CostValuation
core:Non-currentFinancialInstruments
2022-12-31
11092815
core:Non-currentFinancialInstruments
2022-12-31
11092815
core:Non-currentFinancialInstruments
2021-12-31
11092815
bus:SmallEntities
2022-01-01
2022-12-31
11092815
bus:AuditExemptWithAccountantsReport
2022-01-01
2022-12-31
11092815
bus:FullAccounts
2022-01-01
2022-12-31
11092815
bus:SmallCompaniesRegimeForAccounts
2022-01-01
2022-12-31
11092815
bus:PrivateLimitedCompanyLtd
2022-01-01
2022-12-31
11092815
core:OfficeEquipment
2022-01-01
2022-12-31
11092815
core:OfficeEquipment
2022-12-31
COMPANY REGISTRATION NUMBER:
11092815
Filleted Unaudited Financial Statements |
|
Year ended 31 December 2022
Report to the board of directors on the preparation of the unaudited statutory financial statements |
2 |
|
|
Statement of financial position |
3 |
|
|
Notes to the financial statements |
4 |
|
|
Year ended 31 December 2022
The directors present their report and the unaudited financial statements of the company for the year ended
31 December 2022
.
Directors
The directors who served the company during the year were as follows:
Small company provisions
This report has been prepared in accordance with the provisions applicable to companies entitled to the small companies exemption.
This report was approved by the board of directors on
28 September 2023
and signed on behalf of the board by:
Registered office: |
1 Pelham Crescent |
London |
SW7 2NP |
|
Report to the Board of Directors on the Preparation of the Unaudited Statutory Financial Statements of
Pelham Partners Ltd |
|
Year ended 31 December 2022
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Pelham Partners Ltd for the year ended 31 December 2022, which comprise the statement of financial position and the related notes from the company's accounting records and from information and explanations you have given us. As a practising member firm of the Association of Chartered Certified Accountants, we are subject to its ethical and other professional requirements which are detailed at www.accaglobal.com/en/member/professional-standards/rules-standards/acca-rulebook.html. Our work has been undertaken in accordance with the requirements of the Association of Chartered Certified Accountants as detailed at www.accaglobal.com/content/dam/ACCA_Global/Technical/fact/technical-factsheet-163.pdf.
BAILHACHE LINTON LLP
Accountants
Bourne House
475 Godstone Road
Whyteleafe
Surrey
CR3 0BL
28 September 2023
Statement of Financial Position |
|
31 December 2022
Fixed assets
Tangible assets |
4 |
1,081 |
– |
Investments |
5 |
150,350 |
150,350 |
|
--------- |
--------- |
|
151,431 |
150,350 |
|
|
|
|
Creditors: Amounts falling due within one year |
6 |
237,140 |
150,910 |
|
--------- |
--------- |
Net current liabilities |
237,140 |
150,910 |
|
--------- |
--------- |
Total assets less current liabilities |
(
85,709) |
(
560) |
|
-------- |
---- |
Net liabilities |
(
85,709) |
(
560) |
|
-------- |
---- |
|
|
|
|
Capital and reserves
Called up share capital |
1,000 |
1,000 |
Profit and loss account |
(
86,709) |
(
1,560) |
|
-------- |
------- |
Shareholder deficit |
(
85,709) |
(
560) |
|
-------- |
------- |
|
|
|
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.
For the year ending 31 December 2022 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
-
The member has not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476
;
-
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements
.
These financial statements were approved by the
board of directors
and authorised for issue on
28 September 2023
, and are signed on behalf of the board by:
Company registration number:
11092815
Notes to the Financial Statements |
|
Year ended 31 December 2022
1.
General Information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 1 Pelham Crescent, London, SW7 2NP.
2.
Statement of Compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3.
Accounting Policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Tangible assets
Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other comprehensive income and accumulated in equity, except to the extent it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation, is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in equity in respect of that asset. Where a revaluation decrease exceeds the accumulated revaluation gains accumulated in equity in respect of that asset, the excess shall be recognised in profit or loss.
Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
|
Equipment |
- |
33% straight line |
|
|
|
|
Investments
Fixed asset investments are initially recorded at cost, and subsequently stated at cost less any accumulated impairment losses.
Listed investments are measured at fair value with changes in fair value being recognised in profit or loss.
Investments in associates
Investments in associates accounted for in accordance with the cost model are recorded at cost less any accumulated impairment losses. Investments in associates accounted for in accordance with the fair value model are initially recorded at the transaction price. At each reporting date, the investments are measured at fair value, with changes in fair value recognised in other comprehensive income/profit or loss. Where it is impracticable to measure fair value reliably without undue cost or effort, the cost model will be adopted. Dividends and other distributions received from the investment are recognised as income without regard to whether the distributions are from accumulated profits of the associate arising before or after the date of acquisition.
Investments in joint ventures
Investments in jointly controlled entities accounted for in accordance with the cost model are recorded at cost less any accumulated impairment losses. Investments in jointly controlled entities accounted for in accordance with the fair value model are initially recorded at the transaction price. At each reporting date, the investments are measured at fair value, with changes in fair value recognised in other comprehensive income/profit or loss. Where it is impracticable to measure fair value reliably without undue cost or effort, the cost model will be adopted. Dividends and other distributions received from the investment are recognised as income without regard to whether the distributions are from accumulated profits of the joint venture arising before or after the date of acquisition.
Impairment of fixed assets
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that largely independent of the cash inflows from other assets or groups of assets. For impairment testing of goodwill, the goodwill acquired in a business combination is, from the acquisition date, allocated to each of the cash-generating units that are expected to benefit from the synergies of the combination, irrespective of whether other assets or liabilities of the company are assigned to those units.
Financial instruments
A financial asset or a financial liability is recognised only when the company becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Debt instruments are subsequently measured at amortised cost. Where investments in non-convertible preference shares and non-puttable ordinary shares or preference shares are publicly traded or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value with changes in fair value recognised in profit or loss. All other such investments are subsequently measured at cost less impairment. Other financial instruments, including derivatives, are initially recognised at fair value, unless payment for an asset is deferred beyond normal business terms or financed at a rate of interest that is not a market rate, in which case the asset is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Other financial instruments are subsequently measured at fair value, with any changes recognised in profit or loss, with the exception of hedging instruments in a designated hedging relationship.
Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. For all equity instruments regardless of significance, and other financial assets that are individually significant, these are assessed individually for impairment. Other financial assets are either assessed individually or grouped on the basis of similar credit risk characteristics. Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.
4.
Tangible Assets
|
Equipment |
|
£ |
Cost |
|
At 1 January 2022 |
– |
Additions |
1,179 |
|
------- |
At 31 December 2022 |
1,179 |
|
------- |
Depreciation |
|
At 1 January 2022 |
– |
Charge for the year |
98 |
|
------- |
At 31 December 2022 |
98 |
|
------- |
Carrying amount |
|
At 31 December 2022 |
1,081 |
|
------- |
At 31 December 2021 |
– |
|
------- |
|
|
5.
Investments
|
Shares in participating interests |
Loans to participating interests |
Total |
|
£ |
£ |
£ |
Cost |
|
|
|
At 1 January 2022 and 31 December 2022 |
350 |
150,000 |
150,350 |
|
---- |
--------- |
--------- |
Impairment |
|
|
|
At 1 January 2022 and 31 December 2022 |
– |
– |
– |
|
---- |
--------- |
--------- |
|
|
|
|
Carrying amount |
|
|
|
At 31 December 2022 |
350 |
150,000 |
150,350 |
|
---- |
--------- |
--------- |
At 31 December 2021 |
350 |
150,000 |
150,350 |
|
---- |
--------- |
--------- |
|
|
|
|
6.
Creditors:
Amounts falling due within one year
|
2022 |
2021 |
|
£ |
£ |
Other creditors |
237,140 |
150,910 |
|
--------- |
--------- |
|
|
|
7.
Directors' Advances, Credits and Guarantees
As at the year end,
Edward Orf
was owed £149,662
(2021: £149,350)and Roger Orf
was owed £84,357
(2021:Nil). This is included under Other Creditors.
8.
Related Party Transactions
Tene Living UK Ltd A company in which
Pelham Partners Ltd
has significant control. In 2021 the company made an investment in Tene Living UK Ltd. It provided an interest-free unsecured loan facility of £150,000. The loan is repayable ahead of any dividend payments or as agreed between the A Shareholders in writing. This is shown on the Balance Sheet as Loan to Participating Interests.